ArticleCancers2021

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML.

Dyantha I van der Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.